Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 411

1.

Gold Nanoparticles Crossing Blood-Brain Barrier Prevent HSV-1 Infection and Reduce Herpes Associated Amyloid-βsecretion.

I RI, Mj S, R G, Fj M, Mj B, Ma MF.

J Clin Med. 2020 Jan 7;9(1). pii: E155. doi: 10.3390/jcm9010155.

2.

Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank.

Fernández IC, Merino IG, Muñoz-Fernández MÁ.

J Transl Med. 2020 Jan 6;18(1):6. doi: 10.1186/s12967-019-02187-w.

3.

Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth.

Domínguez-Rodríguez S, Tagarro A, Palma P, Foster C, Puthanakit T, Jupimai T, Cotugno N, Ananworanich J, Zangari P, Nastouli E, Muñoz-Fernández MÁ, Navarro ML, Giaquinto C, Rossi P, Kuhn L, Rojo P.

J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):483-490. doi: 10.1097/QAI.0000000000002188.

PMID:
31714427
4.

Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide.

Guerrero-Beltrán C, Prieto A, Leal M, Jiménez JL, Muñoz-Fernández MÁ.

Future Med Chem. 2019 Dec;11(23):3005-3013. doi: 10.4155/fmc-2018-0539. Epub 2019 Nov 11.

PMID:
31710246
5.

Dendritic Cells, the Double Agent in the War Against HIV-1.

Martín-Moreno A, Muñoz-Fernández MA.

Front Immunol. 2019 Oct 23;10:2485. doi: 10.3389/fimmu.2019.02485. eCollection 2019. Review.

6.

How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain.

Suárez-García I, Alejos B, Delgado E, Rivero M, Pineda JA, Jarrin I; Cohort of the Spanish HIV/AIDS Network (CoRIS) study group.

HIV Med. 2020 Feb;21(2):128-134. doi: 10.1111/hiv.12817. Epub 2019 Nov 8.

PMID:
31702111
7.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

Suárez-García I, Ruiz-Algueró M, García Yubero C, Moreno C, Belza MJ, Estébanez M, de Los Santos I, Masiá M, Samperiz Abad G, Muñoz Sánchez J, Omar M, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS) .

J Antimicrob Chemother. 2020 Feb 1;75(2):466-472. doi: 10.1093/jac/dkz439.

PMID:
31665404
8.

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015.

Jiménez de Ory S, Ramos JT, Fortuny C, González-Tomé MI, Mellado MJ, Moreno D, Gavilán C, Menasalvas AI, Piqueras AI, Frick MA, Muñoz-Fernández MA, Navarro ML; CoRISpe Cohort Working Group.

PLoS One. 2019 Oct 24;14(10):e0223536. doi: 10.1371/journal.pone.0223536. eCollection 2019.

9.

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study.

Jiménez-Sousa MÁ, Jiménez JL, Fernández-Rodríguez A, Bellón JM, Rodríguez C, Riera M, Portilla J, Castro Á, Muñoz-Fernández MÁ, Resino S.

J Biomed Sci. 2019 Oct 23;26(1):83. doi: 10.1186/s12929-019-0577-y.

10.

Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children.

Guillén S, Prieto L, Jiménez de Ory S, González-Tomé MI, Rojo P, Navarro ML, Mellado MJ, Escosa L, Sainz T, Francisco L, Muñoz-Fernández MÁ, Ramos JT; CoRISpe (Cohorte Nacional de VIH pediátrica de la RED RIS).

PLoS One. 2019 Aug 5;14(8):e0220552. doi: 10.1371/journal.pone.0220552. eCollection 2019.

11.

Dendronized magnetic nanoparticles for HIV-1 capture and rapid diagnostic.

Barrios-Gumiel A, Sepúlveda-Crespo D, Jiménez JL, Gómez R, Muñoz-Fernández MÁ, de la Mata FJ.

Colloids Surf B Biointerfaces. 2019 Sep 1;181:360-368. doi: 10.1016/j.colsurfb.2019.05.050. Epub 2019 May 23.

PMID:
31158698
12.

Hepatitis C virus and cumulative infections are associated with atherogenic cardiovascular events in HIV-infected subjects.

Genebat M, Tarancón-Díez L, Pulido I, Álvarez-Ríos AI, Muñoz-Fernández MÁ, Ruiz-Mateos E, Leal M.

Antiviral Res. 2019 Sep;169:104527. doi: 10.1016/j.antiviral.2019.05.016. Epub 2019 May 31.

PMID:
31158414
13.

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.

Relaño-Rodríguez I, Juárez-Sánchez R, Pavicic C, Muñoz E, Muñoz-Fernández MÁ.

J Nanobiotechnology. 2019 May 21;17(1):69. doi: 10.1186/s12951-019-0500-4.

14.

G2-S16 dendrimer microbicide does not interfere with the vaginal immune system.

Martín-Moreno A, Sepúlveda-Crespo D, Serramía-Lobera MJ, Perisé-Barrios AJ, Muñoz-Fernández MA.

J Nanobiotechnology. 2019 May 15;17(1):65. doi: 10.1186/s12951-019-0496-9.

15.

New anionic poly(alkylideneamine) dendrimers as microbicide agents against HIV-1 infection.

Maciel D, Guerrero-Beltrán C, Ceña-Diez R, Tomás H, Muñoz-Fernández MÁ, Rodrigues J.

Nanoscale. 2019 May 16;11(19):9679-9690. doi: 10.1039/c9nr00303g.

PMID:
31066407
16.

G1-S4 or G2-S16 carbosilane dendrimer in combination with Platycodin D as a promising vaginal microbicide candidate with contraceptive activity.

Ceña-Diez R, Martin-Moreno A, de la Mata FJ, Gómez-Ramirez R, Muñoz E, Ardoy M, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2019 Apr 2;14:2371-2381. doi: 10.2147/IJN.S188495. eCollection 2019.

17.

Poly(N-vinylcaprolactam) Nanogels with Antiviral Behavior against HIV-1 Infection.

Macchione MA, Guerrero-Beltrán C, Rosso AP, Euti EM, Martinelli M, Strumia MC, Muñoz-Fernández MÁ.

Sci Rep. 2019 Apr 5;9(1):5732. doi: 10.1038/s41598-019-42150-9.

18.

Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients.

Gutiérrez C, Lopez-Abente J, Pérez-Fernández V, Prieto-Sánchez A, Correa-Rocha R, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M.

PLoS One. 2019 Mar 27;14(3):e0213744. doi: 10.1371/journal.pone.0213744. eCollection 2019.

19.

VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients.

Jiménez-Sousa MA, Jiménez JL, Fernández-Rodríguez A, Brochado-Kith O, Bellón JM, Gutierrez F, Díez C, Bernal-Morell E, Viciana P, Muñoz-Fernández MA, Resino S.

J Clin Med. 2019 Mar 5;8(3). pii: E311. doi: 10.3390/jcm8030311.

20.

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers.

Dominguez-Molina B, Ferrando-Martinez S, Tarancon-Diez L, Hernandez-Quero J, Genebat M, Vidal F, Muñoz-Fernandez MA, Leal M, Koup R, Ruiz-Mateos E.

Front Immunol. 2018 Dec 10;9:2897. doi: 10.3389/fimmu.2018.02897. eCollection 2018.

Supplemental Content

Loading ...
Support Center